Software

Absolute Software should recover this year, says Industrial Alliance

Ahead of Absolute Software’s (TSX:ABT) third quarter results, Industrial Alliance analyst Blair Abernethy thinks investors should be buying the stock.
In a research update to clients today, Abernethy maintained his “Buy” rating and one-year price target of $11.00 on Absolute Software, implying a return of 70.5 per cent at the time of publication.
Abernethy says he expects third quarter revenue will come in at $21.5-million, slightly lower than the consensus of $21.6-million, and down 11 per cent from the same period last year. He says this reflects the company’s disposing of two product lines and repositioning its sales efforts. He thinks this will be a temporary lull, however.
“We expect Absolute’s stock to recover this year following the rationalization of products, the issuer bid (C$50M repurchased at C$8.00 last October), partnership traction, and a refocus on sales execution,” says the analyst. “By the second half of 2016, we expect an improved sales contract trajectory to provide more confidence in the stock.”
Abernethy notes that Absolute has expanded its partnerships with the likes of Getac, DDM, and Microsoft. He says he believes the company is considering licensing deals with other software providers and is looking into customized solution opportunities for large customers.

Tagged with: abt
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Verano Holdings is undervalued, Haywood says

Haywood Capital Markets analyst Neal Gilmer says Verano Holdings (Verano Holdings Stock Quote, Chart, News, Analysts, Financials NEO:VRNO) is staying… [Read More]

21 hours ago

Knight Therapeutics is a buy, Stifel says

Knight Therapeutics (Knight Therapeutics Stock Quote, Chart, News, Analysts, Financials TSXV:GUD) is continuing to build momentum, according to Stifel Nicolaus… [Read More]

21 hours ago

Groupon wins price target raise at Roth

Roth Capital Partners has raised its price target on Groupon (Groupon Inc Stock Quote, Chart, News, Analysts, Financials NASDAQ:GRPN) to… [Read More]

22 hours ago

Trulieve Cannabis is a buy, Beacon says

Trulieve Cannabis (Trulieve Cannabis Stock Quote, Chart, News, Analysts, Financials CSE:TRUL) delivered a strong start to fiscal 2025, beating high-end… [Read More]

1 day ago

Green Thumb Industries should be a core holding for cannabis investors, analyst says

Green Thumb Industries (Green Thumb Industries Stock Quote, Chart, News, Analysts, Financials CSE:GTII) delivered a steady first quarter and remains… [Read More]

1 day ago

5N Plus just delivered an “exceptional” quarter, this analyst says

5N Plus (5N Plus Stock Quote, Chart, News, Analysts, Financials TSX:VNP) blew past expectations in the first quarter of 2025,… [Read More]

2 days ago